ERAP2 and familial pancreatic carcinoma: As suggested in Figure 7C, 7D, knockdown of ERAP2 remarkably attenuated the migration ability of pancreatic cancer cell lines, and the invasion ability of pancreatic cancer cell lines was also inhibited.